App-Quantinova.ai

Human and Murine Immune Thrombocytopenia (ITP) Is Associated with a Peripheral Deficiency of CD4- T Regulatory Cells (Tc-regs)

Daoxin Ma - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immune thrombocytopenia

N/A

The International Prospective Glanzman-s Thrombasthenia Registry (GTR) Special Issues in Children

Giovanni di Minno - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Glanzmann thrombasthenia

NiaStase

Enhanced Fibrinolysis by Proteolysed Coagulation Factor Xa Is Inhibited by Rivaroxaban

Kimberley Talbot - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

rivaroxaban

Rates of Malposition and Expulsion of the Levonorgestrel-Releasing Intrauterine System Among Women with Inherited Bleeding Disorders

Mary Anne Jamieson - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Recombinant Factor VIII

Vitamin D and Zinc Deficiency Associated with Increased Pain Episodes in Children with Sickle Cell Disease

Christine G Chretien - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sickle cell anemia

Hydroxyurea

Association Between Increased Liver Iron Concentration and Vitamin D Deficiency in Patients with Transfusion Dependent Hemoglobinopathies in British Columbia

John K. Wu - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Vitamin D deficiency

Parathyroid hormone

The Benefit of Allogeneic Hematopoietic Cell Transplantation in Older Patients with Acute Myeloid Leukemia Is Restricted to Those in First Complete Remission At the Time of Transplantation.

Hans A. Messner - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute myelocytic leukemia

GP2

Small Molecule MIRA-1 Induces p53-Independent Apoptosis in Multiple Myeloma Cells Through Activation of the p38 MAPK Signaling Pathway.

Hua Jiang - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Multiple Myeloma

Dexamethasone

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.

Saad Z Usmani - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Multiple Myeloma

Arginine hydrochloride

PI3K-Independent Signaling Pathways Contribute to ICOS-Mediated T-Cell Costimulation in Acute Graft-Versus-Host Disease in Mice.

Julie Leconte - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Graft-versus-host disease

N/A

Discovering Optimal Targets for Adoptive T-Cell Immunotherapy of Leukemia.

Sarah Hadj-Mimoune - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Graft-versus-host disease

N/A

The Immune Combination Therapy of Leukemia Using Adoptive Transfer and TGF-? Blockade.

Amina Dahmani - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

GM-CSF

Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.

Chakradhara Rao Uppungunduri - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Ursodeoxycholic acid

Improving Rates of Appropriate Venous Thromboembolism Prophylaxis in a Community Hospital.

Danette Beechinor - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Global Trends in Hematopoietic Cell Transplantation.

Mahmoud Aljurf - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lympho proliferative disease

N/A

Metabolomic Biomarkers As Predictors of Iron Load and Oxidative Damage in Iron Overloaded Thalassemia Patients

Ying Zhang - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Acquired pure red cell aplasia

Deferasirox

Diverse Immunophenotypic Abnormalities in Adult Patients with Hemophagocytic Lymphohistiocytosis

Nikisha S Khare - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hemophagocytic lymphohistiocytosis

Etoposide

Ivig Negatively Regulates LPS-Induced Monocytes Activation Through a Microrna-146a Related Mechanism

Renee Bazin - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Interleukin-10

Defined, Serum-Free Conditions for in Vitro culture of Primary Human T-ALL Blasts

Arla J Yost - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

ZoMaxx

A Novel Model of Immune-Mediated Disease Equilibrium in Acute Lymphoblastic Leukemia

David M. Barrett - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Filters

28841 Abstracts